Subscribe for the VF E-News HERE
The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.
Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »
On Thursday, May 18, Brandon Hudgins will be accepting the NORD 2017 Rare Impact Award. The VF nominated Brandon, a record-breaking, elite runner, for his work raising awareness about more »
The Vasculitis Foundation is pleased to present the 2017 Vasculitis Update CME Course for health care professionals in partnership with Northwestern Division of Rheumatology on Saturday, June 24, 2017 from 7:45 more »
The Vasculitis Foundation (VF) announces the winner of its 2017 Recognizing Excellence in Diagnostics (RED) Award. The V-RED Award is presented annually to a medical professional who made a quick diagnosis of more »